These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8996864)
1. Studies on the synthesis and structure-activity relationships of 2-(2-functionalized pyrrolidin-4-ylthio)-1 beta-methylcarbapenems. Lee HW; Kim EN; Son HJ; Ahn SK; Chung KH; Kim JW; Lee CR Chem Pharm Bull (Tokyo); 1996 Dec; 44(12):2326-30. PubMed ID: 8996864 [TBL] [Abstract][Full Text] [Related]
2. A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1 beta-methylcarbapenems. Iso Y; Irie T; Nishino Y; Motokawa K; Nishitani Y J Antibiot (Tokyo); 1996 Feb; 49(2):199-209. PubMed ID: 8621362 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of 1beta-methylcarbapenems with quaternary ammonium side chains. Ishikawa K; Kojima K; Miyauchi M; Endo R; Yasuda H; Kawamoto I J Antibiot (Tokyo); 1998 Aug; 51(8):757-70. PubMed ID: 9766468 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted thiazolo pyrrolidin-3-ylthio)carbapenem derivatives. Oh CH; Cho HW; Baek D; Cho JH Eur J Med Chem; 2002 Sep; 37(9):743-54. PubMed ID: 12350291 [TBL] [Abstract][Full Text] [Related]
5. 1 beta-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems. 3. Synthesis and antibacterial activity of BO-2727 and its related compounds. Ohtake N; Okamoto O; Mitomo R; Kato Y; Yamamoto K; Haga Y; Fukatsu H; Nakagawa S J Antibiot (Tokyo); 1997 Jul; 50(7):598-613. PubMed ID: 9711251 [TBL] [Abstract][Full Text] [Related]
6. A novel carbapenem antibiotic, SM-7338 structure-activity relationships. Sunagawa M; Matsumura H; Inoue T; Fukasawa M; Kato M J Antibiot (Tokyo); 1990 May; 43(5):519-32. PubMed ID: 2358404 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834. Miyauchi M; Endo R; Hisaoka M; Yasuda H; Kawamoto I J Antibiot (Tokyo); 1997 May; 50(5):429-39. PubMed ID: 9207914 [TBL] [Abstract][Full Text] [Related]
8. 1 beta-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems. 2. Synthesis and antibacterial activity of 5-aminopropyl and 5-aminopropenyl pyrrolidine derivatives. Ohtake N; Okamoto O; Kato S; Ushijima R; Fukatsu H; Nakagawa S J Antibiot (Tokyo); 1997 Jul; 50(7):586-97. PubMed ID: 9711250 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of 1beta-methyl-2-[5-(N-substituted-2-hydroxy iminoethyl)pyrrolidin-3-ylthio]carbapenem derivatives. Oh CH; Lee SC; Cho JH Eur J Med Chem; 2003; 38(7-8):751-8. PubMed ID: 12932906 [TBL] [Abstract][Full Text] [Related]
10. CP0569, a new broad-spectrum injectable carbapenem. Part 1: synthesis and structure-activity relationships. Aihara K; Kano Y; Shiokawa S; Sasaki T; Setsu F; Sambongi Y; Ishii M; Tohyama K; Ida T; Tamura A; Atsumi K; Iwamatsu K Bioorg Med Chem; 2003 Aug; 11(16):3475-85. PubMed ID: 12878141 [TBL] [Abstract][Full Text] [Related]
11. 1 beta-Methyl-2(5-substituted pyrrolidin-3-ylthio)carbapenems. 1. Synthesis and antibacterial activity of BO-2502A and its related compounds. Ohtake N; Yamada K; Mano E; Okamoto O; Ushijima R; Nakagawa S J Antibiot (Tokyo); 1997 Jul; 50(7):567-85. PubMed ID: 9711249 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety. Kanno O; Miyauchi M; Shibayama T; Ohya S; Kawamoto I J Antibiot (Tokyo); 1999 Oct; 52(10):900-7. PubMed ID: 10604760 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives. Oh CH; Lee CS; Lee JS; Cho JH Arch Pharm (Weinheim); 2003 Nov; 336(11):504-9. PubMed ID: 14639742 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial evaluation of 1beta-methyl-2-(5-substituted heterocyclic carbamoyl)pyrrolidin-3-ylthio)carbapenem derivatives. Lee JS; Choa JH; Cho H; Oh CH Arch Pharm (Weinheim); 2004 Jul; 337(7):391-7. PubMed ID: 15237389 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial activities of new 1beta-methylcarbapenems having aminopyrimidinylthioether moiety. Lee KS; Lim JH; Kang YK; Yoo KH; Kim DC; Shin KJ; Kim DJ Eur J Med Chem; 2006 Nov; 41(11):1347-51. PubMed ID: 16973246 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of 1beta-methyl-2-[5'-isoxazoloethenylpyrrolidin-3'-ylthio]carbapenems. Kim DJ; Seo KJ; Lee KS; Shin KJ; Yoo KH; Kim DC; Park SW Bioorg Med Chem Lett; 2000 Dec; 10(24):2799-802. PubMed ID: 11133095 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological properties of a new series of anti-MRSA beta-lactams; 2-(thiazol-2-ylthio)carbapenems. Shinagawa H; Yamaga H; Houchigai H; Sumita Y; Sunagawa M Bioorg Med Chem; 1997 Mar; 5(3):601-21. PubMed ID: 9113338 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety. Kawamoto I; Shimoji Y; Kanno O; Kojima K; Ishikawa K; Matsuyama E; Ashida Y; Shibayama T; Fukuoka T; Ohya S J Antibiot (Tokyo); 2003 Jun; 56(6):565-79. PubMed ID: 12931867 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial activity of new carbapenems containing isoxazole moiety. Kang YK; Shin KJ; Yoo KH; Seo KJ; Hong CY; Lee CS; Park SY; Kim DJ; Park SW Bioorg Med Chem Lett; 2000 Jan; 10(2):95-9. PubMed ID: 10673088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]